Delivery Order SPE2DB25D3404-SPE2DB26FUMAP
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, for $2,872.47 on September 23, 2025. The order covers Lantus SoloStar 100 Unit/mL insulin in 3mL quantities and will be performed at the contractor's Conshohocken facility with an ultimate completion date of September 24, 2025. This is a firm fixed-price delivery order issued under a non-set-aside competitive procurement,...
- The Defense Logistics Agency awarded a delivery order valued at $1,338.81 to AmerisourceBergen Drug Corp on May 9, 2025, for the supply of Lantus SoloStar 100 Unit/mL insulin in 3mL formulations. This firm fixed-price delivery order, with an ultimate completion date of May 12, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The award was made through open competition without a set-aside designation, and the product...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Lantus SoloStar 100 Unit/ML 3ML insulin on June 11, 2025, with a ceiling value of $1,917.75. This is a firm fixed price delivery order issued under a non-competitive, non-set-aside procurement. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of June 12, 2025. This delivery order represents a small-value pharmaceutical...
- The Defense Logistics Agency (DLA) awarded a $1,534.20 delivery order to AmerisourceBergen Drug Corp for the supply of Lantus SoloStar 100 Unit/mL insulin in 3mL quantities. The contract, executed on August 6, 2025, with an ultimate completion date of August 7, 2025, utilizes firm fixed pricing under a non-set-aside competitive procurement. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Lantus SoloStar insulin (100 unit/mL, 3mL formulation) with a ceiling value of $1,022.80. This is a firm fixed-price delivery order issued without set-aside designation, indicating competitive award to the vendor. The contract is to be completed by August 21, 2025, with performance occurring at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order valued at $1,022.80 to AmerisourceBergen Drug Corp for the supply of Lantus SoloStar 100 Unit/ML insulin in 3ml quantities. This firm fixed price, competitively awarded contract was issued on July 22, 2025, with an ultimate completion date of July 23, 2025. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order represents a single transaction executed...
- The Defense Logistics Agency awarded a delivery order valued at $7,716.36 to AmerisourceBergen Drug Corp for the supply of Lantus SoloStar 100 Unit/mL insulin in 3mL quantities. This competitive award, issued on November 4, 2025, represents a Firm Fixed Price delivery order with an ultimate completion date of November 5, 2025. The contract will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. As a non-set-aside award, this contract was competed among eligible...
- The Defense Logistics Agency awarded a $1,297.36 delivery order to AmerisourceBergen Drug Corp for the supply of Lantus SoloStar 100 unit/mL insulin in 3mL quantities, with an ultimate completion date of May 5, 2025. This non-set-aside, firm fixed-price contract was competitively awarded and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a single transaction under AmerisourceBergen's broader pharmaceutical supply...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on October 31, 2025, for the supply of Lantus SoloStar 100 Unit/ML 3ML insulin, with a ceiling value of $2,045.60 and an ultimate completion date of November 3, 2025. This is a firm fixed-price delivery order issued under a non-competitive, non-set-aside procurement. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Lantus SoloStar 100 Unit/mL insulin in 3mL quantities, valued at $1,113.75. This competitively awarded, firm fixed-price delivery order was issued on October 23, 2025, with an ultimate completion date of October 24, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This award represents a routine pharmaceutical procurement supporting...
- SPE2DB25D3404Indefinite Delivery Contract
- SPE2DB25D3404-SPE2DB26FUMAPDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,298.48 to AmerisourceBergen Drug Corp on November 12, 2025, for the supply of Lantus SoloStar 100 Unit/mL insulin in 3mL quantities. This firm fixed-price delivery order, which has an ultimate completion date of November 13, 2025, represents a child contract under AmerisourceBergen's larger indefinite delivery contract (IDC) with DLA Troop Support Medical. The award was made through open competition with no set-aside designation, and performance will occur at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's comprehensive $999,999,999.00 IDC with DLA Troop Support Medical (contract number SPE2DX), which extends through December 2026 and serves as a global pharmaceutical support vehicle for military healthcare programs. The parent contract enables AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, and vaccines to support Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems worldwide. The award demonstrates the contractor's continued role as a critical pharmaceutical vendor within the DLA's medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 11/12/25 |